Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome.
Lacroix
A
A
Department of Medicine, Research Center, Pavillon Hôtel-Dieu, Centre Hospitalier de l'Université de Montréal, QC, Canada.
Tremblay
J
J
Rousseau
G
G
Bouvier
M
M
Hamet
P
P
D000311:Adrenal Glands / Q000473:pathology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D002395:Catecholamines / Q000502:physiology; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism* / Q000652:urine; D006965:Hyperplasia; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D006854:Hydrocortisone